I dispositivi negli anziani con scompenso cardiaco cronico

Translated title of the contribution: The devices in the elderly with chronic heart failure

Stefano Fumagalli, Debbie Gabbai, Samuele Baldasseroni, Luigi Padeletti

Research output: Contribution to journalArticle

Abstract

Chronic heart failure(CHF) is a frequent and clinically relevant condition in elderly patients. Despite the improvements in medical therapy, CHF mortality is persistently high. The introduction into clinical practice of pacemakers for cardiac resynchronization therapy(CRT) and of implantable cardioverter- defibrillators(ICD) has significantly increased survival in CHF patients. In spite of clinical and epidemiological data, evidence of the effectiveness of these devices in the elderly is scant, and the few existing data derive from observational studies. Regarding CRT, in 1787 patients, the InSync/InSync ICD study showed no age-related differences in the prevalence of responders to therapy(about 60%) and in procedural complication rates(11%). Regarding ICD, in the 6311 patients enrolled in the Italian Clinical Service Project, 22.6% of the excess mortality observed in older subjects was due to comorbid conditions. Specific controlled clinical trials are needed to address the impact of CRT and ICD on health-related quality of life, disability and cognitive profile. The findings obtained will be useful to clarify clinical, ethical and cost-effectiveness issues in order to develop specific age-oriented guideline recommendations.

Original languageItalian
JournalGiornale Italiano di Cardiologia
Volume14
Issue number3 SUPPL1
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Implantable Defibrillators
Cardiac Resynchronization Therapy
Heart Failure
Equipment and Supplies
Mortality
Controlled Clinical Trials
Cost-Benefit Analysis
Observational Studies
Quality of Life
Guidelines
Survival
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Fumagalli, S., Gabbai, D., Baldasseroni, S., & Padeletti, L. (2013). I dispositivi negli anziani con scompenso cardiaco cronico. Giornale Italiano di Cardiologia, 14(3 SUPPL1). https://doi.org/10.1714/1261.13939

I dispositivi negli anziani con scompenso cardiaco cronico. / Fumagalli, Stefano; Gabbai, Debbie; Baldasseroni, Samuele; Padeletti, Luigi.

In: Giornale Italiano di Cardiologia, Vol. 14, No. 3 SUPPL1, 03.2013.

Research output: Contribution to journalArticle

Fumagalli, S, Gabbai, D, Baldasseroni, S & Padeletti, L 2013, 'I dispositivi negli anziani con scompenso cardiaco cronico', Giornale Italiano di Cardiologia, vol. 14, no. 3 SUPPL1. https://doi.org/10.1714/1261.13939
Fumagalli, Stefano ; Gabbai, Debbie ; Baldasseroni, Samuele ; Padeletti, Luigi. / I dispositivi negli anziani con scompenso cardiaco cronico. In: Giornale Italiano di Cardiologia. 2013 ; Vol. 14, No. 3 SUPPL1.
@article{a4c4949c269c44e791f874a26c2a34a2,
title = "I dispositivi negli anziani con scompenso cardiaco cronico",
abstract = "Chronic heart failure(CHF) is a frequent and clinically relevant condition in elderly patients. Despite the improvements in medical therapy, CHF mortality is persistently high. The introduction into clinical practice of pacemakers for cardiac resynchronization therapy(CRT) and of implantable cardioverter- defibrillators(ICD) has significantly increased survival in CHF patients. In spite of clinical and epidemiological data, evidence of the effectiveness of these devices in the elderly is scant, and the few existing data derive from observational studies. Regarding CRT, in 1787 patients, the InSync/InSync ICD study showed no age-related differences in the prevalence of responders to therapy(about 60{\%}) and in procedural complication rates(11{\%}). Regarding ICD, in the 6311 patients enrolled in the Italian Clinical Service Project, 22.6{\%} of the excess mortality observed in older subjects was due to comorbid conditions. Specific controlled clinical trials are needed to address the impact of CRT and ICD on health-related quality of life, disability and cognitive profile. The findings obtained will be useful to clarify clinical, ethical and cost-effectiveness issues in order to develop specific age-oriented guideline recommendations.",
keywords = "Cardiac resynchronization therapy, Chronic heart failure, Elderly, Implantable cardioverter-defibrillator, Prognosis",
author = "Stefano Fumagalli and Debbie Gabbai and Samuele Baldasseroni and Luigi Padeletti",
year = "2013",
month = "3",
doi = "10.1714/1261.13939",
language = "Italian",
volume = "14",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "3 SUPPL1",

}

TY - JOUR

T1 - I dispositivi negli anziani con scompenso cardiaco cronico

AU - Fumagalli, Stefano

AU - Gabbai, Debbie

AU - Baldasseroni, Samuele

AU - Padeletti, Luigi

PY - 2013/3

Y1 - 2013/3

N2 - Chronic heart failure(CHF) is a frequent and clinically relevant condition in elderly patients. Despite the improvements in medical therapy, CHF mortality is persistently high. The introduction into clinical practice of pacemakers for cardiac resynchronization therapy(CRT) and of implantable cardioverter- defibrillators(ICD) has significantly increased survival in CHF patients. In spite of clinical and epidemiological data, evidence of the effectiveness of these devices in the elderly is scant, and the few existing data derive from observational studies. Regarding CRT, in 1787 patients, the InSync/InSync ICD study showed no age-related differences in the prevalence of responders to therapy(about 60%) and in procedural complication rates(11%). Regarding ICD, in the 6311 patients enrolled in the Italian Clinical Service Project, 22.6% of the excess mortality observed in older subjects was due to comorbid conditions. Specific controlled clinical trials are needed to address the impact of CRT and ICD on health-related quality of life, disability and cognitive profile. The findings obtained will be useful to clarify clinical, ethical and cost-effectiveness issues in order to develop specific age-oriented guideline recommendations.

AB - Chronic heart failure(CHF) is a frequent and clinically relevant condition in elderly patients. Despite the improvements in medical therapy, CHF mortality is persistently high. The introduction into clinical practice of pacemakers for cardiac resynchronization therapy(CRT) and of implantable cardioverter- defibrillators(ICD) has significantly increased survival in CHF patients. In spite of clinical and epidemiological data, evidence of the effectiveness of these devices in the elderly is scant, and the few existing data derive from observational studies. Regarding CRT, in 1787 patients, the InSync/InSync ICD study showed no age-related differences in the prevalence of responders to therapy(about 60%) and in procedural complication rates(11%). Regarding ICD, in the 6311 patients enrolled in the Italian Clinical Service Project, 22.6% of the excess mortality observed in older subjects was due to comorbid conditions. Specific controlled clinical trials are needed to address the impact of CRT and ICD on health-related quality of life, disability and cognitive profile. The findings obtained will be useful to clarify clinical, ethical and cost-effectiveness issues in order to develop specific age-oriented guideline recommendations.

KW - Cardiac resynchronization therapy

KW - Chronic heart failure

KW - Elderly

KW - Implantable cardioverter-defibrillator

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84877777887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877777887&partnerID=8YFLogxK

U2 - 10.1714/1261.13939

DO - 10.1714/1261.13939

M3 - Articolo

VL - 14

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 3 SUPPL1

ER -